Julio Lamprea Montealegre, MD, PhD, MPH

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
AddressFlexible, #001
Varies 00001
ORCID ORCID Icon0000-0002-5999-4287 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Universidad Javeriana, Bogota, ColombiaMD06/2006
    Johns Hopkins , BaltimoreMPH06/2009Epidemiology & Biostatistics
    Johns Hopkins, BaltimorePhD06/2012Cardiovascular Epidemiology
    University of Maryland, BaltimoreResidency06/2015Internal Medicine
    University of Washington, SeattleFellowship06/2018Cardiology

    Collapse Overview 
    Collapse Overview
    Dr. Lamprea-Montealegre is a cardiologist who focuses on preventive cardiology. His clinical interests include preventive cardiology and cardiovascular risk assessment, cardiorenal syndrome, dyslipidemias , heart valve disease, and echocardiography.

    Dr. Lamprea-Montealegre's research focuses on the cardiovascular health consequences of chronic kidney disease. His current projects aim to prevent cardiovascular disease through the early detection and treatment of chronic kidney disease.

    Collapse Research 
    Collapse Research Activities and Funding
    Closing the Cardio-Renal Preventive Treatment Gap Among Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: An Implementation Science Approach
    NHLBI 4R00HL157721-03Feb 1, 2024 - Jan 31, 2027
    Role: PI
    Closing the Cardio-Renal Preventive Treatment Gap Among Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: An Implementation Science Approach
    NIH/NHLBI 1K99HL157721-01A1Feb 1, 2022 - Sep 1, 2027
    Role: PI
    Disparities in cardio-renal care provision among elderly patients of racial and ethnic minorities
    UCSF CADC/NIA P30AG015272Jul 1, 2021 - Jun 30, 2022
    Role: PI
    The dyslipidemia of ESRD: role of triglyceride-rich lipoproteins and association with cardiovascular events
    American Heart Association AHA 18POST34030003Jul 1, 2018 - Jun 30, 2020
    Role: PI

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease. Semin Nephrol. 2024 May 04; 151520. Limonte CP, Lamprea-Montealegre JA, Tuttle KR. PMID: 38705774.
      View in: PubMed   Mentions:
    2. Assessing community-level impacts of and responses to stay at home orders: The King County COVID-19 community study. PLoS One. 2024; 19(2):e0296851. Moloney K, Lamprea Montealegre JA, Busch Isaksen TM, Kennedy M, Archer M, Contreras C, Iyaz D, Randazza J, Silva J, Errett NA. PMID: 38330074; PMCID: PMC10852336.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    3. Unlocking the potential: boosting SGLT2 inhibitor uptake to prevent the cardiorenal consequences of chronic kidney disease. Lancet Reg Health West Pac. 2024 Feb; 43:101004. Lamprea-Montealegre JA. PMID: 38292307; PMCID: PMC10827533.
      View in: PubMed   Mentions:
    4. Population-wide albuminuria screening: implications for CKD detection and management. Lancet. 2023 09 23; 402(10407):1020-1021. Lamprea-Montealegre JA, Estrella MM. PMID: 37597525.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease. JAMA Netw Open. 2023 07 03; 6(7):e2326230. Chu CD, Xia F, Du Y, Singh R, Tuot DS, Lamprea-Montealegre JA, Gualtieri R, Liao N, Kong SX, Williamson T, Shlipak MG, Estrella MM. PMID: 37498594; PMCID: PMC10375308.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    6. Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease. Diabetes Care. 2022 12 01; 45(12):2900-2906. Lamprea-Montealegre JA, Madden E, Tummalapalli SL, Chu CD, Peralta CA, Du Y, Singh R, Kong SX, Tuot DS, Shlipak MG, Estrella MM. PMID: 36156061; PMCID: PMC9998844.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    7. Launching a career as a physician-scientist. Heart. 2022 10 28; 108(22):1832-1833. Lamprea-Montealegre JA, Natarajan P. PMID: 36307207.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol. BMC Nephrol. 2022 10 12; 23(1):331. Lamprea-Montealegre JA, Joshi P, Shapiro AS, Madden E, Navarra K, Potok OA, Gregg LP, Podchiyska T, Robinson A, Goldstein MK, Peralta CA, Jassal SK, Navaneethan SD, Rifkin DE, Wang V, Shlipak MG, Estrella MM. PMID: 36224528; PMCID: PMC9554861.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System. JAMA. 2022 09 06; 328(9):861-871. Lamprea-Montealegre JA, Madden E, Tummalapalli SL, Peralta C, Neilands TB, Garcia PK, Muiru A, Karliner L, Shlipak MG, Estrella MM. PMID: 36066519; PMCID: PMC9449794.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    10. Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts. J Am Heart Assoc. 2022 08 02; 11(15):e024012. Lamprea-Montealegre JA, Arnold AM, McCLelland RL, Mukamal KJ, Djousse L, Biggs ML, Siscovick DS, Tracy RP, Beisswenger PJ, Psaty BM, Ix JH, Kizer JR. PMID: 35904195; PMCID: PMC9375486.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Improving cardiovascular health through healthy lifestyle behaviours: time to think beyond willpower. Heart. 2022 04; 108(7):496-497. Lamprea-Montealegre JA. PMID: 35121577.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Too Many for Too Few: Finding Appropriate Nephrology Referrals for Patients With CKD That Optimize Outcomes. Am J Kidney Dis. 2022 03; 79(3):330-332. Chu CD, Lamprea-Montealegre JA, Estrella MM. PMID: 35031165.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Valvular Heart Disease in Relation to Race and Ethnicity: JACC Focus Seminar 4/9. J Am Coll Cardiol. 2021 12 14; 78(24):2493-2504. Lamprea-Montealegre JA, Oyetunji S, Bagur R, Otto CM. PMID: 34886971.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types. JAMA Health Forum. 2021; 2(12):e214205. Sri Lekha Tummalapalli; Julio Lamprea Montealegre; Neil Warnock; Michael Green; Said A. Ibrahim; Michelle M. Estrella. .
    15. Triglyceride-Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End-Stage Renal Disease on Hemodialysis. Am J Cardiol. 2021 08 01; 152:63-68. Lamprea-Montealegre JA, Katz R, Scharnagl H, Silbernagel G, März W, Drechsler C, Wanner C, de Boer IH. PMID: 34108090.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Aortic and mitral valve calcification as markers of atherosclerotic cardiovascular disease risk. Eur Heart J Cardiovasc Imaging. 2021 02 22; 22(3):271-272. Lamprea-Montealegre JA, Otto CM. PMID: 33164050.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention. Heart. 2021 08; 107(16):1282-1288. Lamprea-Montealegre JA, Shlipak MG, Estrella MM. PMID: 33568433.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    18. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD. Clin J Am Soc Nephrol. 2020 01 07; 15(1):47-60. Lamprea-Montealegre JA, Staplin N, Herrington WG, Haynes R, Emberson J, Baigent C, de Boer IH, SHARP Collaborative Group. PMID: 31831577; PMCID: PMC6946066.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    19. Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2019 12 17; 8(24):e013713. Lamprea-Montealegre JA, McClelland RL, Otvos JD, Mora S, Koch M, Jensen MK, de Boer IH. PMID: 31818211; PMCID: PMC6951074.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    20. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2019 08 06; 8(15):e012200. Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, Christenson R, Seliger SL, Soliman EZ, Deo R, Ky B, Feldman HI, Kusek JW, deFilippi CR, Wolf MS, Shafi T, Go AS, Bansal N, CRIC Study Investigators. PMID: 31379242; PMCID: PMC6761652.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    21. Prevalence of Hypertension and Cardiovascular Risk According to Blood Pressure Thresholds Used for Diagnosis. Hypertension. 2018 09; 72(3):602-609. Lamprea-Montealegre JA, Zelnick LR, Hall YN, Bansal N, de Boer IH. PMID: 30354757; PMCID: PMC6205214.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    22. Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes. Diabetes Care. 2018 06; 41(6):1132-1133. Lamprea-Montealegre JA, de Boer IH. PMID: 29784697; PMCID: PMC6463735.
      View in: PubMed   Mentions: 2     Fields:    
    23. Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients. BMC Nephrol. 2018 05 03; 19(1):107. Boulware LE, Ephraim PL, Ameling J, Lewis-Boyer L, Rabb H, Greer RC, Crews DC, Jaar BG, Auguste P, Purnell TS, Lamprea-Monteleagre JA, Olufade T, Gimenez L, Cook C, Campbell T, Woodall A, Ramamurthi H, Davenport CA, Choudhury KR, Weir MR, Hanes DS, Wang NY, Vilme H, Powe NR. PMID: 29724177; PMCID: PMC5934897.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    24. Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease. Heart. 2018 09; 104(17):1455-1460. Lamprea-Montealegre JA, McClelland RL, Grams M, Ouyang P, Szklo M, de Boer IH. PMID: 29472290.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    25. Health Behaviors and Calcific Aortic Valve Disease. J Am Heart Assoc. 2018 02 03; 7(3). Lamprea-Montealegre JA, Otto CM. PMID: 29431108; PMCID: PMC5850268.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study. Atherosclerosis. 2014 May; 234(1):42-6. Lamprea-Montealegre JA, Sharrett AR, Matsushita K, Selvin E, Szklo M, Astor BC. PMID: 24607852.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    27. Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am J Kidney Dis. 2013 Nov; 62(5):953-73. Purnell TS, Auguste P, Crews DC, Lamprea-Montealegre J, Olufade T, Greer R, Ephraim P, Sheu J, Kostecki D, Powe NR, Rabb H, Jaar B, Boulware LE. PMID: 23725972; PMCID: PMC3809150.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    28. Chronic kidney disease, plasma lipoproteins, and coronary artery calcium incidence: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2013 Mar; 33(3):652-8. Lamprea-Montealegre JA, McClelland RL, Astor BC, Matsushita K, Shlipak M, de Boer IH, Szklo M. PMID: 23329135.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    29. CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol. 2012 Nov; 7(11):1777-85. Lamprea-Montealegre JA, Astor BC, McClelland RL, de Boer IH, Burke GL, Sibley CT, O'Leary D, Sharrett AR, Szklo M. PMID: 22879436; PMCID: PMC3488943.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    30. Validity in scale-testing. 2007; 36(2):340-348. Lamprea-Montealegre JA, Gomez-Restrepo C. View Publication.
    Julio's Networks
    Concepts (112)
    Derived automatically from this person's publications.
    Co-Authors (16)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department